1. Combination therapy in multiple sclerosis;Cohen,2007
2. Nordic trial of oral methylprednisolone as add-on therapy to interferon beta-1a for treatment of relapsing-remitting multiple sclerosis (NORMIMS study): randomised controlled trial;Sorensen;Lancet Neurol,2009
3. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS;Cohen;Neurology,2009
4. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS;Zivadinov;Neurology,2001
5. Ravnborg M, Sorensen PS, Andersson ML, et al. A multi-centre, double blind, randomized, placebo controlled, parallel group trial investigating methylprednisolone (MP) as add-on to interferon beta-1a for the treatment of relapsing-remitting multiple sclerosis. Presented at the American Academy of Neurology 2009 Annual Meeting. Seattle, WA, USA. April, 2009. Abstract LB3.002.